Cargando…
Early Identification of Fragile X Syndrome through Expanded Newborn Screening
Over the past 20 years, research on fragile X syndrome (FXS) has provided foundational understanding of the complex experiences of affected individuals and their families. Despite this intensive focus, there has been little progress on earlier identification, with the average age of diagnosis being...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356907/ https://www.ncbi.nlm.nih.gov/pubmed/30609779 http://dx.doi.org/10.3390/brainsci9010004 |
_version_ | 1783391669519908864 |
---|---|
author | Okoniewski, Katherine C. Wheeler, Anne C. Lee, Stacey Boyea, Beth Raspa, Melissa Taylor, Jennifer L. Bailey, Donald B. |
author_facet | Okoniewski, Katherine C. Wheeler, Anne C. Lee, Stacey Boyea, Beth Raspa, Melissa Taylor, Jennifer L. Bailey, Donald B. |
author_sort | Okoniewski, Katherine C. |
collection | PubMed |
description | Over the past 20 years, research on fragile X syndrome (FXS) has provided foundational understanding of the complex experiences of affected individuals and their families. Despite this intensive focus, there has been little progress on earlier identification, with the average age of diagnosis being 3 years. For intervention and treatment approaches to have the greatest impact, they need to begin shortly after birth. To access this critical timespan, differential methods of earlier identification need to be considered, with an emerging focus on newborn screening practices. Currently, barriers exist that prevent the inclusion of FXS on standard newborn screening panels. To address these barriers, an innovative program is being implemented in North Carolina to offer voluntary screening for FXS under a research protocol, called Early Check. This program addresses the difficulties observed in prior pilot studies, such as recruitment, enrollment, lab testing, and follow-up. Early Check provides an opportunity for stakeholders and the research community to continue to gain valuable information about the feasibility and greater impact of newborn screening on the FXS population. |
format | Online Article Text |
id | pubmed-6356907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63569072019-02-05 Early Identification of Fragile X Syndrome through Expanded Newborn Screening Okoniewski, Katherine C. Wheeler, Anne C. Lee, Stacey Boyea, Beth Raspa, Melissa Taylor, Jennifer L. Bailey, Donald B. Brain Sci Review Over the past 20 years, research on fragile X syndrome (FXS) has provided foundational understanding of the complex experiences of affected individuals and their families. Despite this intensive focus, there has been little progress on earlier identification, with the average age of diagnosis being 3 years. For intervention and treatment approaches to have the greatest impact, they need to begin shortly after birth. To access this critical timespan, differential methods of earlier identification need to be considered, with an emerging focus on newborn screening practices. Currently, barriers exist that prevent the inclusion of FXS on standard newborn screening panels. To address these barriers, an innovative program is being implemented in North Carolina to offer voluntary screening for FXS under a research protocol, called Early Check. This program addresses the difficulties observed in prior pilot studies, such as recruitment, enrollment, lab testing, and follow-up. Early Check provides an opportunity for stakeholders and the research community to continue to gain valuable information about the feasibility and greater impact of newborn screening on the FXS population. MDPI 2019-01-03 /pmc/articles/PMC6356907/ /pubmed/30609779 http://dx.doi.org/10.3390/brainsci9010004 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Okoniewski, Katherine C. Wheeler, Anne C. Lee, Stacey Boyea, Beth Raspa, Melissa Taylor, Jennifer L. Bailey, Donald B. Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title_full | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title_fullStr | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title_full_unstemmed | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title_short | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
title_sort | early identification of fragile x syndrome through expanded newborn screening |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356907/ https://www.ncbi.nlm.nih.gov/pubmed/30609779 http://dx.doi.org/10.3390/brainsci9010004 |
work_keys_str_mv | AT okoniewskikatherinec earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT wheelerannec earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT leestacey earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT boyeabeth earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT raspamelissa earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT taylorjenniferl earlyidentificationoffragilexsyndromethroughexpandednewbornscreening AT baileydonaldb earlyidentificationoffragilexsyndromethroughexpandednewbornscreening |